Market Overview

UPDATE: Burrill Initiates Sangamo Biosciences at Market Outperform

Related SGMO
UPDATE: J.P. Morgan Initiates Coverage On Sangamo Biosciences On Potentially Disruptive Future
Benzinga's Top Initiations

Burrill initiated coverage on Sangamo Biosciences (NASDAQ: SGMO) with a Market Outperform rating and a $28.00 price target.

Burrill noted, "We believe Sangamo's innovative genome editing approach could provide novel and transformative therapeutics, which could revolutionize the treatment of genetic disorders. … We believe there is a significant upside to our valuation, given the additional opportunities embedded in the platform, not to mention ex-U.S. markets, which aren't included in our calculation."

Sangamo Biosciences closed at $8.82 on Friday.

Posted-In: BurrillAnalyst Color Initiation Analyst Ratings

 

Related Articles (SGMO)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters